Featured Strategy

Mirae Asset

Quality corporate bond ETF exposure for steady fixed-income returns with an emphasis on credit quality.

Learn more
CategoryFixed Income
No. of ETFs5 ETFs
Review CycleMonthly Review
Horizon2–4 Years

Performance

How this portfolio has performed

Compare growth against a benchmark across timelines and see what a hypothetical investment would be worth today.

In the period of
Amount (₹)00.3K0.5K0.8K1K1.3KOctDecFebAprJunAugTime

Overview

Understand this portfolio

Key metrics, suitability, and strategy highlights to help you evaluate whether this model portfolio fits your goals.

Investment Objective

Fixed Income

Quality corporate bond ETF exposure for steady fixed-income returns with an emphasis on credit quality. Designed for investors seeking a rules-based fixed income model portfolio built with ETFs.

No. of ETFs

5 ETFs

Suggested Horizon

2–4 Years

Review Cycle

Monthly

Min. Investment

₹5,000

Who this may be suitable for

Investors aligned with a low risk profile who want a rules-based fixed income model portfolio built with ETFs.

What investors should keep in mind

Mirae Asset Corporate Bond Plus is subject to market risk and may experience drawdowns of up to 2.4%. Past performance does not guarantee future results.

  • Transparent ETF-based exposure
  • Rules-based review and rebalancing framework
  • Fixed Income
  • Debt

Holdings

Portfolio constituents and weights

Review the ETF mix and segment allocation that defines this model portfolio.

Log in to view holdings and allocation details

FAQs

Got questions? We've got answers!

Common questions about Mirae Asset Corporate Bond Plus and what to expect when you invest.

Mirae Asset Corporate Bond Plus is a rules-based ETF model portfolio focused on fixed income exposure. Quality corporate bond ETF exposure for steady fixed-income returns with an emphasis on credit quality.

Collateral

Documents and timelines

Download portfolio documents and review the scheduled rebalance checkpoints for this strategy.

Rebalance Timelines

  • Q1 Review — January 2026

    Quarterly allocation check against model targets and drift thresholds.

  • Q2 Review — April 2026

    Mid-year review of macro signals, risk metrics, and sleeve performance.

  • Q3 Review — July 2026

    Thematic and factor sleeve review with updated market regime assessment.

  • Q4 Review — October 2026

    Year-end reset to target weights and annual strategy documentation update.